510(k) Report

510(k) · Cleared

Cleared

Smart Syringe

K171698510(k) SpecialCleared Jul 7, 201729-day reviewClass II21 CFR 870.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Osprey Medical, Inc. · DXT Injector And Syringe, Angiographic

Cleared on Jul 7, 2017 as substantially equivalent to K163054 (Osprey Medical, Inc., 2017) after a 29-day review. Its family tree reaches back 11 generations to 1982. 1 later device descends from it.

Decided
Jul 7, 2017
Review
29 days
Class
Class II
Product code
DXT
Recalls
None
Predicates
1

Its longest line of descent runs back 11 generations to K822536 (1982). 20 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 11 generations backK822536 MARK VMedrad, Inc. · 1982
  2. 7 generations between
  3. 3 generations backK153141 DyeVert Contrast Modulation SystemOsprey Medical, Inc. · 2016
  4. 2 generations backK161505 DyeVert NG Contrast Modulation SystemOsprey Medical, Inc. · 2016
  5. 1 generation backK163054 DyeVert Plus Contrast Modulation/Monitoring System, Contrast…Osprey Medical, Inc. · 2017
  6. This deviceK171698 Smart SyringeOsprey Medical, Inc. · 2017
  7. Descendant · cites it directly · 0 of its ownK183267 DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast…Osprey Medical, Inc. · 2018
Show all 11 generations
  1. Root · 11 generations backK822536 MARK VMedrad, Inc. · 1982
  2. 10 generations backK963982 Acist Angiographic InjectorInvasatec · 1997
  3. 9 generations backK984058 Acist Injector System, Model CL100 HAcist Medical Systems · 1999
  4. 8 generations backK991103 Modification to Acist CL 100HAcist Medical Systems · 2000 · Recalled
  5. 7 generations backK131478 Contrast Conservation SystemOsprey Medical, Inc. · 2013
  6. 6 generations backK140425 Contrast Modulation SystemOsprey Medical, Inc. · 2014
  7. 5 generations backK150485 AVERT Contrast Modulation SystemOsprey Medical, Inc. · 2015
  8. 4 generations backK151300 AVERT Contrast Modulation SystemOsprey Medical, Inc. · 2015
  9. 3 generations backK153141 DyeVert Contrast Modulation SystemOsprey Medical, Inc. · 2016
  10. 2 generations backK161505 DyeVert NG Contrast Modulation SystemOsprey Medical, Inc. · 2016
  11. 1 generation backK163054 DyeVert Plus Contrast Modulation/Monitoring System, Contrast…Osprey Medical, Inc. · 2017
  12. This deviceK171698 Smart SyringeOsprey Medical, Inc. · 2017

Most influential descendants

Showing 1 of 1 · See all
  • K183267DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast Reduction System…Osprey Medical, Inc. · 2018 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−11K822536MARK VMedrad, Inc.1982—
−10K963982Acist Angiographic InjectorInvasatec1997—
−9K984058Acist Injector System, Model CL100 HAcist Medical Systems1999—
−8K991103Modification to Acist CL 100HAcist Medical Systems20003
−7K131478Contrast Conservation SystemOsprey Medical, Inc.2013—
−6K140425Contrast Modulation SystemOsprey Medical, Inc.2014—
−5K150485AVERT Contrast Modulation SystemOsprey Medical, Inc.2015—
−4K151300AVERT Contrast Modulation SystemOsprey Medical, Inc.2015—
−3K153141DyeVert Contrast Modulation SystemOsprey Medical, Inc.2016—
−2K161505DyeVert NG Contrast Modulation SystemOsprey Medical, Inc.2016—
−1K163054DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring SystemOsprey Medical, Inc.2017—
0 (this device)K171698Smart SyringeOsprey Medical, Inc.2017—
+1K183267DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast Reduction…Osprey Medical, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
199910
200020
200510
201110
201410
201510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
FIG. 1 — Lineage of K171698, 1982–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXT device

  1. #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K163054DyeVert Plus Contrast Modulation/Monitoring System, Contrast Monitoring System
Summary page 4
…ssification: II CFR Reference: 21 CFR § 870.1650 Product Code: DXT 510(k) number(s) K163054 Page 1 of 3 Comparison to the Predicate Device: The proposed devic…
Osprey Medical, Inc.2017—

Also cleared against K163054: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K183267DyeVert™ NG Contrast Reduction System, DyeVert™ PLUS EZ Contrast Reduction System…Osprey Medical, Inc.20180

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 35 years and passes through 4 companies; a new generation was cleared every 9 months on median.
  • 3 of the 20 ancestors have a recall of any class.
  • Of its descendants, K183267 (Osprey Medical, Inc., 2018) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K163054.

How does its category compare?

All DXT devices

DXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · DXT

1in 2025

2007: 32008: 22009: 62010: 12011: 42013: 22014: 62015: 72016: 82017: 72018: 92019: 42020: 32021: 12023: 12024: 42025: 12026 (partial year): 7
2007high 9 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXT

138in 2024

2007: 182 days median2009: 137 days median2011: 69 days median2014: 144 days median2015: 153 days median2016: 172 days median2017: 183 days median2018: 93 days median2019: 96 days median2020: 154 days median2024: 138 days median2026 (partial year): 264 days median
2007high 264 (2026) · low 69 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXT

10in 2024

2007: 42008: 32009: 72010: 32011: 32012: 72015: 12018: 22020: 12021: 12023: 22024: 102026 (partial year): 6
2007high 10 (2024) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXT

97in 2025

2007: 1072008: 1682009: 1882010: 1242011: 1332012: 1352013: 1412014: 972015: 1352016: 1522017: 1282018: 1292019: 1212020: 932021: 1322022: 1112023: 1172024: 1182025: 97
2007high 188 (2009) · low 93 (2020)2025

MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731824107
20082—3168
200961377188
20101—3124
20114693133
20120—7135
20132—0141
20146144097
201571531135
201681720152
201771830128
20189932129
20194960121
20203154193
20211—1132
20220—0111
20231—2117
2024413810118
20251—097
202672646—

What is it indicated for?

The Smart Syringe is to be used with the DyeVert Plus Contrast Reduction System or the Contrast Monitoring System. The DyeVert Plus Contrast Reduction System is to be used for contrast volume reduction and for the monitoring of radiopaque contrast media during angiographic or CT procedures with the following agents: Iodixanol 270 or 320 mgI/mL, Iohexol 300 or 350 mgI/mL and Iopamidol 370 mgI/mL. The Contrast Monitoring System is to be used during angiographic or CT procedures requiring controlled infusion of radiopaque contrast media.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171698: Smart Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171698

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026